Loading clinical trials...
Loading clinical trials...
Heart failure is the most common cause of death of patients on chronic hemodialysis treatment, and to date there is no effective therapy for the treatment of this comorbidity in this group of patients...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Clinical Hospital Mostar
NCT07656168 · ESRD (End-Stage Renal Disease), Maintenance Hemodialysis
NCT06422871 · End Stage Renal Disease, Hemodialysis Access Failure
NCT07560436 · Heart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease
NCT07285291 · Hyperphosphatemia Patients on Hemodialysis
NCT07462741 · Hemodialysis Patient, Diabetes Foot Care
University Clinical Hospital Mostar
Mostar
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions